Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says
Richard Pestell To Lead Lombardi Cancer Cente
Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds
Mass. Requires Coverage of Routine Patient Care In Clinical Trials
Funding Opportunities
Trending Stories
- Mace Rothenberg’s museum will tell the stories behind breakthroughs in medicine
- Melanoma investigators invite FDA to publicly discuss approval endpoints and crossover design
The agency accepts the invitation - A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Group chairs propose funding strategy to jump-start correlative studies
- Karen Knudsen to leave ACS
- 2024 Lasker Awards honor discoveries in antitumor immunity, GLP-1-based drugs, and research, advocacy in HIV/AIDS